(MedPage Today) — NEW ORLEANS — Patients experiencing major heart attacks had a lower risk of serious complications if they received a single injection of the investigational drug zalunfiban at first medical contact, a randomized placebo-controlled…
Source link : https://www.medpagetoday.com/meetingcoverage/aha/118485
Author :
Publish date : 2025-11-12 22:09:00
Copyright for syndicated content belongs to the linked Source.
